Evidence map›Paper›PMID 30657390›Full record

ArticleJCO clinical cancer informatics2017

Toward Electronic Surveillance of Invasive Mold Diseases in Hematology-Oncology Patients: An Expert System Combining Natural Language Processing of Chest Computed Tomography Reports, Microbiology, and Antifungal Drug Data.

Michelle R Ananda-Rajah, Christoph Bergmeir, François Petitjean, Monica A Slavin, Karin A Thursky, Geoffrey I Webb

Open access · greenAbstract read
In one paragraph

Article in JCO clinical cancer informatics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Artificial intelligence in antimicrobial stewardship: a systematic review and meta-analysis of predictive performance and diagnostic accuracy.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. An overview on the current available treatment for COVID-19 and the impact of antibiotic administration during the pandemic.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2021
    Review
  9. Supportive care in cancer-a MASCC perspective.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2020
    Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Michelle R Ananda-RajahMichelle R. Ananda-Rajah, Alfred Health; Michelle R. Ananda-Rajah, Christoph Bergmeir, François Petitjean, and Geoffrey I. Webb, Monash University; and Monica A. Slavin and Karin A. Thursky, Peter Doherty Centre for Infection and Immunity; University of Melbourne, Melbourne, Victoria, Australia.
Christoph BergmeirMichelle R. Ananda-Rajah, Alfred Health; Michelle R. Ananda-Rajah, Christoph Bergmeir, François Petitjean, and Geoffrey I. Webb, Monash University; and Monica A. Slavin and Karin A. Thursky, Peter Doherty Centre for Infection and Immunity; University of Melbourne, Melbourne, Victoria, Australia.
François PetitjeanMichelle R. Ananda-Rajah, Alfred Health; Michelle R. Ananda-Rajah, Christoph Bergmeir, François Petitjean, and Geoffrey I. Webb, Monash University; and Monica A. Slavin and Karin A. Thursky, Peter Doherty Centre for Infection and Immunity; University of Melbourne, Melbourne, Victoria, Australia.
Monica A SlavinMichelle R. Ananda-Rajah, Alfred Health; Michelle R. Ananda-Rajah, Christoph Bergmeir, François Petitjean, and Geoffrey I. Webb, Monash University; and Monica A. Slavin and Karin A. Thursky, Peter Doherty Centre for Infection and Immunity; University of Melbourne, Melbourne, Victoria, Australia.
Karin A ThurskyMichelle R. Ananda-Rajah, Alfred Health; Michelle R. Ananda-Rajah, Christoph Bergmeir, François Petitjean, and Geoffrey I. Webb, Monash University; and Monica A. Slavin and Karin A. Thursky, Peter Doherty Centre for Infection and Immunity; University of Melbourne, Melbourne, Victoria, Australia.
Geoffrey I WebbMichelle R. Ananda-Rajah, Alfred Health; Michelle R. Ananda-Rajah, Christoph Bergmeir, François Petitjean, and Geoffrey I. Webb, Monash University; and Monica A. Slavin and Karin A. Thursky, Peter Doherty Centre for Infection and Immunity; University of Melbourne, Melbourne, Victoria, Australia.
Peter Doherty Institute · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeProspective epidemiologic surveillance of invasive mold disease (IMD) in hematology patients is hampered by the absence of a reliable laboratory prompt. This study develops an expert system for electronic surveillance of IMD that combines probabilities using natural language processing (NLP) of computed tomography (CT) reports with microbiology and antifungal drug data to improve prediction of IMD.

methodsMicrobiology indicators and antifungal drug-dispensing data were extracted from hospital information systems at three tertiary hospitals for 123 hematology-oncology patients. Of this group, 64 case patients had 26 probable/proven IMD according to international definitions, and 59 patients were uninfected controls. Derived probabilities from NLP combined with medical expertise identified patients at high likelihood of IMD, with remaining patients processed by a machine-learning classifier trained on all available features.

resultsCompared with the baseline text classifier, the expert system that incorporated the best performing algorithm (naïve Bayes) improved specificity from 50.8% (95% CI, 37.5% to 64.1%) to 74.6% (95% CI, 61.6% to 85.0%), reducing false positives by 48% from 29 to 15; improved sensitivity slightly from 96.9% (95% CI, 89.2% to 99.6%) to 98.4% (95% CI, 91.6% to 100%); and improved receiver operating characteristic area from 73.9% (95% CI, 67.1% to 80.6%) to 92.8% (95% CI, 88% to 97.5%).

conclusionAn expert system that uses multiple sources of data (CT reports, microbiology, antifungal drug dispensing) is a promising approach to continuous prospective surveillance of IMD in the hospital, and demonstrates reduced false notifications (positives) compared with NLP of CT reports alone. Our expert system could provide decision support for IMD surveillance, which is critical to antifungal stewardship and improving supportive care in cancer.

Indexed as

Medical OncologyAdultAgedAged, 80 and overAlgorithmsAntifungal AgentsCase-Control StudiesCombined Modality TherapyElectronic Health RecordsExpert SystemsFemaleHumansInvasive Fungal InfectionsMachine LearningMaleMicrobiological TechniquesAntifungal Agents

Identifiers

PMID30657390
PMCPMC6873951
OpenAlexW2751638132

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.